Authorizes students to carry prescribed auto-injectable epinephrine in school.
BILL NUMBER:S2210A REVISED 5/7/13
TITLE OF BILL: An act to amend the education law, in relation to the use of prescribed auto-injectable epinephrine by students
PURPOSE OF BILL: This bill would allow pupils who have been diagnosed with severe food or other allergies to carry and use the prescribed medication epinephrine and a device to self-administer epinephrine during the school day and during school sponsored activities.
EFFECTS OF PRESENT LAW WHICH THIS BILL WOULD ALTER: Adds a new section 921 to the Education Law
SUMMARY OF SPECIFIC PROVISIONS: The education law is amended by adding a new section 921 which allows students who have been diagnosed by a physician or other authorized health care provider with a severe food or other allergy to carry and use the prescribed medication epinephrine and a device to self-administer epinephrine.
JUSTIFICATION: The following information is taken from the American Academy of Asthma, Allergy and Immunology position Statement on Anaphylaxis in Schools: Life-threatening severe allergic reactions can cause the condition Anaphylaxis which is a collection of symptoms including breathing difficulties and a drop in blood pressure or shock, which are potentially fatal. Common examples of potentially life-threatening allergies are those to foods and stinging insects. Life-threatening allergic reactions may also occur to medications or latex rubber and in association with exercise. It is estimated that 1% to 2% of the general population is at risk for anaphylaxis from food allergies and insect. stings, with a lower reported prevalence for drugs and latex. Asthmatic subjects are at particular risk. Approximately 50 anaphylactic deaths caused by insect stings and 100 food-related anaphylactic deaths are recognized each year in the U.S.
It is imperative that epinephrine be recognized as the drug of choice and that all efforts are directed toward its immediate use. Data clearly shows that fatalities more often occur away from home and are associated with either not using epinephrine or a delay in the use of epinephrine treatment. Accidental food ingestion can occur despite avoidance measures. Treatment should be immediately available for these emergency situations.
Epinephrine injection is available in a number of self-administration delivery devices. There are no contraindications to the use of epinephrine for a life-threatening allergic reaction. With parental consent, and their doctor's prescription, children old enough to self-administer epinephrine should carry their own epinephrine auto-inject kits.
LEGISLATIVE HISTORY: 2004 - A.11093 2005 - A.2166 - Referred to Education 2007/2008 - A.3921- Referred to Education 2009/2010 - A.2471 - Referred to Education
FISCAL IMPLICATIONS FOR STATE AND LOCAL GOVERNMENTS: No fiscal implication.
EFFECTIVE DATE: 120 days after it becomes law; however, the Commissioner of Education is authorized immediately to promulgate rules and regulations for the implementation of this act on such effective date.
STATE OF NEW YORK ________________________________________________________________________ 2210--A 2013-2014 Regular Sessions IN SENATE January 14, 2013 ___________Introduced by Sens. RANZENHOFER, MAZIARZ -- read twice and ordered printed, and when printed to be committed to the Committee on Educa- tion -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the education law, in relation to the use of prescribed auto-injectable epinephrine by students THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The education law is amended by adding a new section 921 to read as follows: S 921. PUPILS AFFLICTED WITH SEVERE FOOD OR OTHER ALLERGIES. 1. THE BOARD OF EDUCATION OR TRUSTEES OF EACH SCHOOL DISTRICT AND BOARD OF COOPERATIVE EDUCATIONAL SERVICES SHALL ALLOW PUPILS WHO HAVE BEEN DIAG- NOSED BY A PHYSICIAN OR OTHER DULY AUTHORIZED HEALTH CARE PROVIDER WITH A SEVERE FOOD OR OTHER ALLERGY TO CARRY AND USE PRESCRIBED AUTO-INJECTA- BLE EPINEPHRINE, DURING THE SCHOOL DAY AND DURING SCHOOL SPONSORED ACTIVITIES THAT OCCUR AFTER THE REGULAR SCHOOL DAY OR OUTSIDE OF THE SCHOOL, WITH THE WRITTEN PERMISSION OF A PHYSICIAN OR OTHER DULY AUTHOR- IZED HEALTH CARE PROVIDER, AND WRITTEN PARENTAL CONSENT, BASED ON SUCH PHYSICIAN'S OR PROVIDER'S DETERMINATION THAT SUCH PUPIL IS SUBJECT TO ALLERGIC ATTACKS SEVERE ENOUGH TO DEBILITATE SUCH PUPIL. A RECORD OF SUCH PERMISSION SHALL BE MAINTAINED IN THE SCHOOL OFFICE. 2. NOTWITHSTANDING ANY OTHER PROVISION OF LAW, RULE OR REGULATION TO THE CONTRARY NO PARTY SHALL HAVE A CAUSE OF ACTION FOR PERSONAL INJURY OR ANY OTHER CLAIM BASED ON THE USE OF PRESCRIBED AUTO-INJECTABLE EPINEPHRINE BY A SCHOOL DISTRICT OR BOARD OF COOPERATIVE EDUCATIONAL SERVICES, ITS AGENT, A SCHOOL OFFICER, EMPLOYEE OR VOLUNTEER AT THE SCHOOL OR A SCHOOL-SPONSORED FUNCTION, PROVIDED THAT SUCH USE WAS PERFORMED REASONABLY AND IN GOOD FAITH. S 2. This act shall take effect on the one hundred twentieth day after it shall have become a law; provided, however, that effective immediate- ly the commissioner of education is authorized to promulgate rules and regulations for the implementation of this act on such effective date.EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD06864-02-3